IU Health and the Indiana University Melvin and Bren Simon Comprehensive Cancer Center plans to develop a state-wide mobile lung cancer screening program as a result of a $4.5 million gift from The Tom and Julie Wood Family Foundation, which includes $4 million matching dollars from Indiana University Health.
A head-to-head comparison of five leading treatments for anaplastic lymphoma kinase-positive non-small cell lung cancer could help oncologists fine-tune first-line TKI selection beyond what’s been seen in clinical trials alone, according to a study conducted by a team of researchers from the Keck School of Medicine of USC, the USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences and the USC Shaeffer Center for Health Policy & Economics have conducted.
